The “Entrepreneurial State” and the Leveraging of Life in the Field of Regenerative Medicine
暂无分享,去创建一个
[1] Georgina Born,et al. Logics of interdisciplinarity , 2008 .
[2] Claes-Fredrik Helgesson,et al. Value Practices in the Life Sciences and Medicine , 2015 .
[3] C. Mason,et al. A brief definition of regenerative medicine. , 2008, Regenerative medicine.
[4] D. Sipp. Conditional approval: Japan lowers the bar for regenerative medicine products. , 2015, Cell stem cell.
[5] Nafees N. Malik. Reimbursement and adoption of advanced therapies: the 5-C framework. , 2014, Regenerative medicine.
[6] C. Parish. Stem the tide. , 2002, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[7] Christine Hauskeller,et al. The clinician-scientist: professional dynamics in clinical stem cell research. , 2012, Sociology of health & illness.
[8] Patrik Aspers,et al. Theory, Reality, and Performativity in Markets , 2007 .
[9] J. Gardner. Patient-centred medicine and the broad clinical gaze: Measuring outcomes in paediatric deep brain stimulation , 2017 .
[10] Nafees N. Malik. Pay-for-performance pricing for a breakthrough heart drug: learnings for cell and gene therapies. , 2016, Regenerative medicine.
[11] I. Wilkinson. The House Of Lords Select Committee for Science and Technology. Their report on complementary and alternative medicine and its implications for reflexology. . . , 2002, Complementary therapies in nursing & midwifery.
[12] M. Mazzucato. The Entrepreneurial State: Debunking Public vs Private Sector Myths (an excerpt) , 2015, Journal of Economic Sociology.
[13] S. Schwartzman,et al. The New Production of Knowledge: The Dynamics of Science and Research in Contemporary Societies , 1994 .
[14] R. V. Schomberg. A Vision of Responsible Research and Innovation , 2013 .
[15] L. Bromham,et al. Interdisciplinary research has consistently lower funding success , 2016, Nature.
[16] A. Faulkner,et al. Are there specific translational challenges in regenerative medicine? Lessons from other fields. , 2015, Regenerative medicine.
[17] J. Tait,et al. Regenerative Medicine: Business Models, Venture Capital and the Funding Gap , 2014 .
[18] Andrew Webster,et al. Accelerating Innovation in the Creation of Biovalue , 2017, Science, technology & human values.